Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-25-003546
Filing Date
2025-10-23
Accepted
2025-10-23 06:02:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10834
  Complete submission text file 0001178913-25-003546.txt   12623
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Subject) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93797 | Film No.: 251411275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 ITZHAK SADE BUILDING A 29TH FLOOR TEL AVIV L3 6777520
Business Address 4 ITZHAK SADE BUILDING A 29TH FLOOR TEL AVIV L3 6777520 972-3-6845535
SPHERA FUNDS MANAGEMENT LTD. (Filed by) CIK: 0001496201 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SCHEDULE 13G/A